Abicht, Angela

P 1081. PTEN-Associated Macrocephaly in a 3-Year-Old Girl

P 409. The Noonan’s Syndrome as a Differential Diagnosis of a Congenital Myasthenic Syndrome

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

P 1077. Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation (LBSL): A Case Report

Adam, Kristine

P 329. Patients with Juvenile Huntington’s Disease Benefit from Early Diagnosis

P 326. Developments in Stem Cell Transplantation in Lysosomal Storage Diseases—An Update on the Example of Mucopolysaccharidoses

P 736. Benign Enlargement of Subarachnideal Spaces and Subdural Hematoma in an Infant: Spontaneous Bleeding, Child Abuse, or Bleeding Disorder?

Adam, Rüdiger

P 1106. Involvement of the Cardial Autonomous Nervous System in Mitochondrial Neurogastrointestinal Encephalopathy Syndrome

Ajayi, Temitayo

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Aktas, Orhan

P 1168. Management of Highly Active MS in Children: Successful Early Escalation Therapy with Alemtuzumab

Alfano, Lindsay N.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Alhaddad, Bader

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Almusafri, Fatima

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Althaus, Jürgen

FV 837. Early Withdrawal of Antiepileptic Medication in Patients with Juvenile Myoclonic Epilepsy Is Justifiable!

P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy

P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Altmüller, Janine

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Al-Zaidy, Samiah

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Amedick, Lucas Bastian

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Ammann, Louisa

FV 300. Living with Severe Rare Chronic Neurological Disease in Childhood: Family Burden and Quality of Life in Families with MLD and PCH2

Antonio-Arce, Victoria San

FV 269. Cannabidiol for Treatment of Childhood Epilepsy—A Cross-Sectional Survey

Arens, Michael

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

Arnold, W. Dave

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Asenbauer, Elisabeth

FV 588. Probing Homeostatic and Metaplastic Mechanisms of Synaptic Plasticity in Human Primary Motor Cortex Using High-Frequent Quadri-pulse Theta Burst Stimulation

Assmann, Birgit

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Auber, Bernd

P 411. GNAO1-Associated Hyperkinetic-Dystonic Movement Disorder and Developmental Delay in a 14-Year-Old Girl

Badura, Katharina

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

P 1152. Assessment of Therapeutically Guided Serious Gaming from the Point of View of the Treated Children and Adolescents—A Pilot Study

Balci, Meral

P 857. Unusual Presentation of Three Children with Alexander’s Disease and Therapy with Steroids

Balg, Stefanie

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Balmer, Christian

FV 571. Cardiac Kids with Stroke

Baltsavias, Gerasimos

FV 820. Pediatric Moyamoya Angiopathy: A Rapid Progressive Disease in Children < 5 Years of Age

Bamborschke, Daniel

P 1001. A Pathogenic GABRB3 Variant Is Associated with Cleft Palate in a Patient with Epileptic Encephalopathy

Bast, Thomas

FV 510. Influence of Anticonvulsive Treatment on the EEG and the Neuropsychological Features in Children with Rolandic Epilepsy

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

Bauer, Angela

FV 776. sEMG Biofeedback Therapy in Children with Cerebral Palsy

Baumann, Matthias

P 855. Epidemiology of Neuromyelitis Optica Spectrum Disorders in Children and Adolescents

Baumgartner, Matthias R.

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Baumkötter, Jochen

P 1111. Case Report of a Juvenile Patient with Niemann–Pick’s Disease Type C

Bayram, Dilan

P 882. Four-Level Release (Rideau) and Glucocorticoid Therapy in Patients with DMD—Additive Positive Effect on Ambulation

Beblo, Skadi

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Becker, Kerstin

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Becker, Lena-Luise

P 306. Role of Cdk5rap2 in Neocortical Development

Beck-Wödl, Stefanie

FV 943. Facilitating a Molecular Diagnosis as Soon as Possible: Diagnostic Exome in Neurometabolic Disorders

P 1155. Focal Epilepsy Difficult to Treat in Hermann–Pallister’s Syndrome (KBG Syndrome)

Beghetti, Maurice

FV 571. Cardiac Kids with Stroke

Begtrup, Amber

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Behnecke, Anne

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Bernert, Günther

P 898. SMArtCARE: Longitudinal Data Collection of Patients with Spinal Muscular Atrophy in German-Speaking Countries

Bernhard, Matthias K.

FV 918. How Do Pediatricians and General Practitioners Deal with Epilepsy Patients? Results of a Structured Interview

Berry, Katherine

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Bertsche, Astrid

FV 918. How Do Pediatricians and General Practitioners Deal with Epilepsy Patients? Results of a Structured Interview

FV 921. What Do Teachers Know about Epileptic Seizures or Epilepsy in School?

P 1011. Think Unusual—Developmental Delay Plus: Multimodal Diagnosis of Menkes’ Syndrome

Bertsche, Thilo

FV 918. How Do Pediatricians and General Practitioners Deal with Epilepsy Patients? Results of a Structured Interview

Berweck, Steffen

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

P 1152. Assessment of Therapeutically Guided Serious Gaming from the Point of View of the Treated Children and Adolescents—A Pilot Study

Beschle, Judith

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Bettendorf, Markus

P 780. Misdiagnosis of Child Abuse—Fibrodysplasia Ossificans Progressiva as a Therapy-Relevant Differential Diagnosis in Infancy

Betzler, Cornelia

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

Beyerlein, Andreas

FV 330. Have We Done Wrong? Long-Term Follow-up of Cardiovascular Risk Factors in Glut1-Deficiency Treated with Ketogenic Diet Therapies

Bhathal, Hari

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

Bien, Christian G.

P 556. Ketogenic Dietary Therapies—Retrospective Assessment of 143 Children Treated at the Bethel Epilepsy Center from 2003 to 2016

Bigi, Sandra

FV 513. A Potential Risk of Inadequate Prognosis in Hypothermic Children after Asphyxia with Delayed Abnormalities in Diffusion-Weighted Images

Biskup, Saskia

P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy

P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Blakely, Emma

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Blankenburg, Markus

P 1139. Gradenigo’s Syndrome: Two New Case Studies

Blaschek, Astrid

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

FV 658. Cognitive Impairment, Depression, Fatigue, and Quality of Life in Pediatric-Onset Multiple Sclerosis: Results of the Multiple Sclerosis Inventory of Cognition in ADOlescents Study

P 913. Heterozygous Nonsense Variant in the TCF20 Gene as a Cause of Congenital Myopathy

Bluemchen, Katharina

P 1092. The Challenging Nature of Cerebral TBC Manifestations in Children and Young Adults

Bodensteiner, Christoph

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

Boie, G.

FV 1091. C1-esterase Inhibitor Treatment Prevents Blood–Brain Barrier Dysfunction in the Neonatal Mouse Brain after Acute Systemic Hypoxia

Boltshauser, Eugen

P 295. Everolimus Trial for a Patient with Bannayan–Riley–Ruvalcaba’s Syndrome and Progressive Lipomatosis

Bonfert, Michaela Veronika

FV 510. Influence of Anticonvulsive Treatment on the EEG and the Neuropsychological Features in Children with Rolandic Epilepsy

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Bonnen, Penelope

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Borell, Sabine

FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire

Borggräfe, Ingo

FV 510. Influence of Anticonvulsive Treatment on the EEG and the Neuropsychological Features in Children with Rolandic Epilepsy

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Bornheimer, Annalena

FV 449. Cerebral Blood Flow Volume and Gray Matter Volume across a Wide Age Range

Bösing, Hendrik

P 973. Case Report of a 13-Year-Old Boy with Multiple Sclerosis and Obesity Caused by a MC4-Receptor Mutation

Boy, Nikolas

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Brämswig, Nuria

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

Brand, Joerg

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

Brandl, Ulrich

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Brenner, Sebastian

P 916. Lissencephaly and Prolonged Survival of a Male Infant with MICPCH and a Noval Mutation in the CASK Gene, Xp11.4

Brentrup, Angela

FV 1177. Genetic Causes of Congenital Hydrocephalus

Breu, Markus

FV 1016. Antibodies against Neurofascin Are Associated with Severe und Chronic Forms of Guillain–Barré’s Syndrome

Breuer, Anna Sophie

P 379. Objective Assessment of Central Nervous Odor Processing in Infancy

Brockmann, Knut

FV 1119. Incidence of Epilepsies and Epileptic Syndromes in Children and Adolescents: A Prospective Study in Göttingen, Germany in 2014

FV 1118. The Acquisition of Rare Neurological Disorders in Childhood (“ESNEK”)—Interim Results after 4 Years

Broser, Philip

P 1166. Isolated Oculomotor Nerve Palsy as Primary Manifestation of Guillain–Barré’s Syndrome—A Case Report with Focus on Clinical and Electrophysiological Features

Broser, Philip Julian

FV 183. Comparison of the Early Auditory Evoked Potentials during the First Month of Life in Term and Preterm Children

FV 113. Electrophysiological Diagnostic of Neuromuscular Diseases in Newborns, Infants, and Toddlers

Brösse, Ines

P 694. TRIP12 Variants as a Cause of Mental Disability with or without Autism

Brotschi, Barbara

FV 571. Cardiac Kids with Stroke

Brunner-Kainz, Michaela

P 1030. MRI Pattern in Neurodegeneration with Brain Iron Accumulation and Fucosidosis Appear Similar

Buchert, Rebecca

FV 943. Facilitating a Molecular Diagnosis as Soon as Possible: Diagnostic Exome in Neurometabolic Disorders

Buchert-Lo, Rebecca

P 968. Vitamine B6-Dependent Epilepsy in a 14-Year-Old Girl with Drug-Resistant Seizures and Recurring Status Epilepticus

Buelow, Markus

P 328. Novel Homozygous Variants Confirm SPTBN4-Related Congenital Myopathy and Expand the Clinical Phenotype

Buerki, Sarah

FV 183. Comparison of the Early Auditory Evoked Potentials during the First Month of Life in Term and Preterm Children

Burdach, Stefan

P 1079. Early Diagnosis of Neuromyelitis Optica Spectrum Disease as a Prerequisite for Optimal Therapy Management—Report of a Case

Burghes, Arthur H. M.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Cahan, Heather

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Calabrese, Pasquale

FV 658. Cognitive Impairment, Depression, Fatigue, and Quality of Life in Pediatric-Onset Multiple Sclerosis: Results of the Multiple Sclerosis Inventory of Cognition in ADOlescents Study

Camara, Rokya

FV 1165. Limb Ischemia and Arterial Ischemic Stroke in a Newborn: Coincidence or Common Cause?

Candova, Antonia

P 1014. Neurodevelopmental Outcome in VLWB Preterm Infants with Neonatal Seizures Born between 2008 and 2011 at the Age of 2 Years

Castiglia, Lucia

P 366. 7q11.23 Microduplication Syndrome: Neurophysiological and Neuroradiological Insights into a Rare Chromosomal Disorder

Ceulemans, Berten

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Ceylan, Burcin

P 409. The Noonan’s Syndrome as a Differential Diagnosis of a Congenital Myasthenic Syndrome

Chmelnik, Martin

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

Christ, Stine

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Church, Joseph

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Church, Kathleen

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Ciesla, Luise

P 648. The Influence of Secondary Untethering on Bladder Function of Spina Bifida Patients

Cirak, Sebahatin

P 1001. A Pathogenic GABRB3 Variant Is Associated with Cleft Palate in a Patient with Epileptic Encephalopathy

Cirak, Sebahattin

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

FV 992. Dominant SCN2A Mutation Causes Familial Episodic Ataxia and Impairment of Speech Development

Classen, Georg

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Coci, Emanuele

P 366. 7q11.23 Microduplication Syndrome: Neurophysiological and Neuroradiological Insights into a Rare Chromosomal Disorder

Contreras, Adriana

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

Cornell, Sonia

FV 510. Influence of Anticonvulsive Treatment on the EEG and the Neuropsychological Features in Children with Rolandic Epilepsy

Cross, J. Helen

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

Dafsari, Hormos Salimi

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

Daimagüler, Hülya-Secan

P 1001. A Pathogenic GABRB3 Variant Is Associated with Cleft Palate in a Patient with Epileptic Encephalopathy

Daimagüler, Hülya-Sevcan

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

Damm, Manuela

P 1139. Gradenigo’s Syndrome: Two New Case Studies

Danchenko, N.

IP 467. Botulinum Toxin Type A in the Management of Spasticity in Children—A Systematic Literature Review and Bayesian Network Meta-analysis

Dannenberg, Fabian

P 1098. Intravenous Nimodipine Ameliorating an Episode of Sporadic Hemiplegic Migraine with Prolonged Hemiplegia and Severe Disturbances of Cognition

Das, Anibh M.

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Daseking, Monika

P 1032. Cognitive Development in Children with Rolandic Epilepsy or Rolandic EEG Pattern—Preliminary Results of a Prospective Follow-up Study

Datta, Alexandre

FV 571. Cardiac Kids with Stroke

Deba, Timo

FV 837. Early Withdrawal of Antiepileptic Medication in Patients with Juvenile Myoclonic Epilepsy Is Justifiable!

FV 921. What Do Teachers Know about Epileptic Seizures or Epilepsy in School?

P 967. IRIS—A Dreaded Complication of Tuberculous Meningitis

Decker, Christine

P 564. Psychosocial Surrounding as an Important Influencing Factor with Hereditary Sensory and Autonomic Neuropathy—Two Case Reports

P 326. Developments in Stem Cell Transplantation in Lysosomal Storage Diseases—An Update on the Example of Mucopolysaccharidoses

P 736. Benign Enlargement of Subarachnideal Spaces and Subdural Hematoma in an Infant: Spontaneous Bleeding, Child Abuse, or Bleeding Disorder?

Dehmel, Maria

P 916. Lissencephaly and Prolonged Survival of a Male Infant with MICPCH and a Noval Mutation in the CASK Gene, Xp11.4

Deiters, Ludger

P 1014. Neurodevelopmental Outcome in VLWB Preterm Infants with Neonatal Seizures Born between 2008 and 2011 at the Age of 2 Years

de Los Reyes, Emily

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Denecke, Jonas

P 960. Intrathecal Administration of Nusinersen in Patients with SMA: Experience and Challenges—A Single-Center Report

P 1147. Pyridostigmine Leads to Relevant Improvement of Motor Function in an Infant with RYR1-Related Congenital Myopathy

Desimoni, Desiree

FV 1016. Antibodies against Neurofascin Are Associated with Severe und Chronic Forms of Guillain–Barré’s Syndrome

Devinsky, Orrin

IP 110. Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet’s Syndrome: Results of an Open-Label Extension Trial (GWPCARE5)

Didonato, Nataliya

P 916. Lissencephaly and Prolonged Survival of a Male Infant with MICPCH and a Noval Mutation in the CASK Gene, Xp11.4

Diebold, Isabel

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Dieckmann, Andrea

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Diedrich, Sabine

FV 205. Parkinsonism after Coxsackievirus B3 Brain Stem Encephalitis

Dimitrov, Bianca

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Dincer, Yasemin

FV 1031. Whole Exome Sequencing for Children with Dyskinetic Movement Disorder

Distelmaier, Felix

P 1164. Pre-wallerian Degeneration versus New Ischemic Infarction

Doege, Corinna

P 1176. Unfamiliar Interactions of Antiepileptic Drugs

Donkels, Catharina

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

Döring, Jan Henje

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

P 780. Misdiagnosis of Child Abuse—Fibrodysplasia Ossificans Progressiva as a Therapy-Relevant Differential Diagnosis in Infancy

Dorn, Franziska

FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience

Dötsch, Jörg

P 1001. A Pathogenic GABRB3 Variant Is Associated with Cleft Palate in a Patient with Epileptic Encephalopathy

Dreha-Kulaczewski, Steffi

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Dreiwes, Claudia

P 1176. Unfamiliar Interactions of Antiepileptic Drugs

Drenckhahn, Anne

P 334. Severe Leigh-like Phenotype in an Girl with Homozygous p.Q139* Mutation in C12orf65

Driemeyer, Joenna

P 960. Intrathecal Administration of Nusinersen in Patients with SMA: Experience and Challenges—A Single-Center Report

Drozdowska, Alina

P 235. Short-Term Effects of Lunch with Varying Glycemic Index on Children’s Cognitive Function—CogniDo GI-II

Egger, Stephan

P 788. MOG-Ab Positive Acute Disseminated Encephalomyelitis with Asymmetric Lesions in Basal Ganglia and in Thalami

Eich, Gwendolyn

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Eichinger, Michael

P 1106. Involvement of the Cardial Autonomous Nervous System in Mitochondrial Neurogastrointestinal Encephalopathy Syndrome

Eisenhardt, Steffen U.

FV 947. What, When, and for Whom?—Reconstructive Surgery for Congenital Complete and Partial Facial Palsy

Eismann, Caroline

P 451. Clinical Presentation of Children and Adolescents with Neurofibromatosis Type I

Elgizouli, Magdeldin

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Elia, Maurizio

P 366. 7q11.23 Microduplication Syndrome: Neurophysiological and Neuroradiological Insights into a Rare Chromosomal Disorder

Ensenauer, Regina

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Faignart, Nicole

FV 571. Cardiac Kids with Stroke

Falkenstein, Michael

P 235. Short-Term Effects of Lunch with Varying Glycemic Index on Children’s Cognitive Function—CogniDo GI-II

Farfel, Gail

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Fassbender, Jessica

P 1086. Role of PTRH2 in Cerebellar Development

Fazeli, Walid

FV 992. Dominant SCN2A Mutation Causes Familial Episodic Ataxia and Impairment of Speech Development

FV 1165. Limb Ischemia and Arterial Ischemic Stroke in a Newborn: Coincidence or Common Cause?

P 613. IQSEC2-Associated X-Coupled Mental Retardation 1 in a Girl with Difficult-to-Treat Epilepsy

P 1001. A Pathogenic GABRB3 Variant Is Associated with Cleft Palate in a Patient with Epileptic Encephalopathy

Fiedler, Barbara

FV 837. Early Withdrawal of Antiepileptic Medication in Patients with Juvenile Myoclonic Epilepsy Is Justifiable!

FV 921. What Do Teachers Know about Epileptic Seizures or Epilepsy in School?

FV 1178. The More the Merrier? Diagnostic Yield of EEG after the First Unprovoked Seizure

FV 1177. Genetic Causes of Congenital Hydrocephalus

P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy

P 967. IRIS—A Dreaded Complication of Tuberculous Meningitis

P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Fink, Christian

P 366. 7q11.23 Microduplication Syndrome: Neurophysiological and Neuroradiological Insights into a Rare Chromosomal Disorder

Fischer, Meike

FV 969. Transplantation Surgery Used Autologous Transgenic Keratinocyte Cultures Which Regenerated an Entire, Fully Functional Epidermis

Fischer, Michal

P 1106. Involvement of the Cardial Autonomous Nervous System in Mitochondrial Neurogastrointestinal Encephalopathy Syndrome

Fluss, Joel

FV 571. Cardiac Kids with Stroke

Foust, Kevin D.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Frank, Diana

FV 1177. Genetic Causes of Congenital Hydrocephalus

Frank, Nathalie

P 1111. Case Report of a Juvenile Patient with Niemann–Pick’s Disease Type C

Freisinger, Peter

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Frölich, Saskia

FV 300. Living with Severe Rare Chronic Neurological Disease in Childhood: Family Burden and Quality of Life in Families with MLD and PCH2

Funk, Julia

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

P 882. Four-Level Release (Rideau) and Glucocorticoid Therapy in Patients with DMD—Additive Positive Effect on Ambulation

Galer, Bradley S.

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Gammaitoni, Arnold

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Garbade, Sven

P 781. A Cross-sectional Quantitative Analysis of the Natural History of Farber Disease: An Ultra-Orphan Condition with Rheumatologic and Neurological Cardinal Disease Features

Garbade, Sven F.

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Gärtner, Jutta

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Gattinger, Norbert

FV 588. Probing Homeostatic and Metaplastic Mechanisms of Synaptic Plasticity in Human Primary Motor Cortex Using High-Frequent Quadri-pulse Theta Burst Stimulation

Geiger, Julia

P 295. Everolimus Trial for a Patient with Bannayan–Riley–Ruvalcaba’s Syndrome and Progressive Lipomatosis

Gellrich, Janine

P 379. Objective Assessment of Central Nervous Odor Processing in Infancy

Genrich, Geeske

P 1176. Unfamiliar Interactions of Antiepileptic Drugs

Gerstl, Julia

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

Gerstl, Lucia

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

FV 510. Influence of Anticonvulsive Treatment on the EEG and the Neuropsychological Features in Children with Rolandic Epilepsy

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Gill, Esther

P 328. Novel Homozygous Variants Confirm SPTBN4-Related Congenital Myopathy and Expand the Clinical Phenotype

Gil-Nagel, Antonio

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

Gissen, Paul

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Glaser, Tanja

P 327. Is Video-Assisted Methylphenidate Dose Finding for Children with ADHD a Suitable Procedure for Medical Practitioners?—Results after 4-Year-Follow-up

Gläser, Dieter

P 913. Heterozygous Nonsense Variant in the TCF20 Gene as a Cause of Congenital Myopathy

Gleich, Bernhard

FV 588. Probing Homeostatic and Metaplastic Mechanisms of Synaptic Plasticity in Human Primary Motor Cortex Using High-Frequent Quadri-pulse Theta Burst Stimulation

Gnann, Silja

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Goelz, Rangmar

FV 930. Reduced Structural Connectivity in Nonmotor Networks in Children Born Preterm

Gonzalez-Fassreiner, Daniela

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Göpel, Wolfgang

FV 1170. What Influences Motor Function in VLBW Preterm at 5 Years of Age?

Gratzki, Nils

P 1014. Neurodevelopmental Outcome in VLWB Preterm Infants with Neonatal Seizures Born between 2008 and 2011 at the Age of 2 Years

Grehten, Patrice

P 233. Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder

Grimmel, Mona

FV 943. Facilitating a Molecular Diagnosis as Soon as Possible: Diagnostic Exome in Neurometabolic Disorders

Gröschel, Samuel

FV 930. Reduced Structural Connectivity in Nonmotor Networks in Children Born Preterm

FV 300. Living with Severe Rare Chronic Neurological Disease in Childhood: Family Burden and Quality of Life in Families with MLD and PCH2

FV 188. Morbus Krabbe: One disease—Two Faces

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Gross, Stephanie

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Gruber-Sedlmayr, Ursula

P 788. MOG-Ab Positive Acute Disseminated Encephalomyelitis with Asymmetric Lesions in Basal Ganglia and in Thalami

P 1030. MRI Pattern in Neurodegeneration with Brain Iron Accumulation and Fucosidosis Appear Similar

Grulich-Henn, Jürgen

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Grünert, Sarah C.

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Guyot, P.

IP 467. Botulinum Toxin Type A in the Management of Spasticity in Children—A Systematic Literature Review and Bayesian Network Meta-analysis

Haack, Tobias

FV 735. UBTF-Related Dementia and Parkinsonism—Case Report of a Novel Disease Entity

FV 943. Facilitating a Molecular Diagnosis as Soon as Possible: Diagnostic Exome in Neurometabolic Disorders

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

P 968. Vitamine B6-Dependent Epilepsy in a 14-Year-Old Girl with Drug-Resistant Seizures and Recurring Status Epilepticus

P 1030. MRI Pattern in Neurodegeneration with Brain Iron Accumulation and Fucosidosis Appear Similar

Haas, Carola A.

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

Haas, Dorothea

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Haber, Benjamin

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Häberle, Johannes

P 233. Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder

Hackenberg, Annette

FV 735. UBTF-Related Dementia and Parkinsonism—Case Report of a Novel Disease Entity

FV 571. Cardiac Kids with Stroke

FV 820. Pediatric Moyamoya Angiopathy: A Rapid Progressive Disease in Children < 5 Years of Age

Hagberg, Gisela

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Hahn, Gabriele

P 916. Lissencephaly and Prolonged Survival of a Male Infant with MICPCH and a Noval Mutation in the CASK Gene, Xp11.4

Haidich, Anna-Bettina

FV 183. Comparison of the Early Auditory Evoked Potentials during the First Month of Life in Term and Preterm Children

Halimeh, Susan

P 736. Benign Enlargement of Subarachnideal Spaces and Subdural Hematoma in an Infant: Spontaneous Bleeding, Child Abuse, or Bleeding Disorder?

Hanebeck, Benjamin

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Harmsen, Stefani

P 1164. Pre-wallerian Degeneration versus New Ischemic Infarction

Harting, Inga

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Hartmann, Hans

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

P 411. GNAO1-Associated Hyperkinetic-Dystonic Movement Disorder and Developmental Delay in a 14-Year-Old Girl

Hasselmann, Oswald

FV 113. Electrophysiological Diagnostic of Neuromuscular Diseases in Newborns, Infants, and Toddlers

Hauenstein, Christina

P 1011. Think Unusual—Developmental Delay Plus: Multimodal Diagnosis of Menkes’ Syndrome

Hauser, Till-Karsten

FV 695. Does Early Postnatal hCMV Infection Have Long-Term Consequences on Brain Structure of Former Preterm Born Children?

FV 930. Reduced Structural Connectivity in Nonmotor Networks in Children Born Preterm

Hehr, Ute

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Heinen, Florian

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

FV 510. Influence of Anticonvulsive Treatment on the EEG and the Neuropsychological Features in Children with Rolandic Epilepsy

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Heller, Corina

P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Helling-Bakki, Astrid

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Hennes, Eva-Maria

P 855. Epidemiology of Neuromyelitis Optica Spectrum Disorders in Children and Adolescents

Hennig, Bert

FV 571. Cardiac Kids with Stroke

Henrich, Maria

P 409. The Noonan’s Syndrome as a Differential Diagnosis of a Congenital Myasthenic Syndrome

Hentschel, Franziska

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

Henzi, Bettina

FV 571. Cardiac Kids with Stroke

Herberhold, Thomas

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

Heringer, Jana

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Herkenrath, Peter

P 613. IQSEC2-Associated X-Coupled Mental Retardation 1 in a Girl with Difficult-to-Treat Epilepsy

P 1001. A Pathogenic GABRB3 Variant Is Associated with Cleft Palate in a Patient with Epileptic Encephalopathy

Hermann, Katharina

P 1147. Pyridostigmine Leads to Relevant Improvement of Motor Function in an Infant with RYR1-Related Congenital Myopathy

Hermann-Alves, Sofia

FV 330. Have We Done Wrong? Long-Term Follow-up of Cardiovascular Risk Factors in Glut1-Deficiency Treated with Ketogenic Diet Therapies

Hernandez-Miranda, Luis Rodrigo

P 1086. Role of PTRH2 in Cerebellar Development

Herting, Arne

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Herting, Egbert

FV 1170. What Influences Motor Function in VLBW Preterm at 5 Years of Age?

Hesse, Nikolas

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

Hethey, Sven

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Heußinger, Nicole

FV 330. Have We Done Wrong? Long-Term Follow-up of Cardiovascular Risk Factors in Glut1-Deficiency Treated with Ketogenic Diet Therapies

Heyer, Christoph

P 736. Benign Enlargement of Subarachnideal Spaces and Subdural Hematoma in an Infant: Spontaneous Bleeding, Child Abuse, or Bleeding Disorder?

Hildebrandt, Martin

P 518. Vitamin B6-Dependent West’s Syndrome: An Unexplained Case

Hillenbrand, Nikolas

P 1092. The Challenging Nature of Cerebral TBC Manifestations in Children and Young Adults

Himes, Ryan

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Hinze, Claas

P 967. IRIS—A Dreaded Complication of Tuberculous Meningitis

Hobbiebrunken, Elke

FV 1119. Incidence of Epilepsies and Epileptic Syndromes in Children and Adolescents: A Prospective Study in Göttingen, Germany in 2014

Hoffjan, Sabine

P 564. Psychosocial Surrounding as an Important Influencing Factor with Hereditary Sensory and Autonomic Neuropathy—Two Case Reports

Hoffmann, Florian

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

Hoffmann, Georg F.

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

P 605. Epileptic Encephalopathy Caused by Mitochondrial MPC-1 Deficiency Can Benefit from Ketogenic Diet—Significance of Early Genetic Testing for a Targeted Therapy

Hoffmann, Georg Friedrich

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

P 781. A Cross-sectional Quantitative Analysis of the Natural History of Farber Disease: An Ultra-Orphan Condition with Rheumatologic and Neurological Cardinal Disease Features

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

P 694. TRIP12 Variants as a Cause of Mental Disability with or without Autism

P 705. Axenfeld-Rieger Anomaly and Neuropsychiatric Symptoms

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

P 780. Misdiagnosis of Child Abuse—Fibrodysplasia Ossificans Progressiva as a Therapy-Relevant Differential Diagnosis in Infancy

Hofmann-Peters, Anne

P 556. Ketogenic Dietary Therapies—Retrospective Assessment of 143 Children Treated at the Bethel Epilepsy Center from 2003 to 2016

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Hofstetter, Peter

P 1092. The Challenging Nature of Cerebral TBC Manifestations in Children and Young Adults

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

Holinski-Feder, Elke

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Holz, Anja

P 613. IQSEC2-Associated X-Coupled Mental Retardation 1 in a Girl with Difficult-to-Treat Epilepsy

Horn, Annette

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

Hörtnagel, Konstanze

P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy

Hu, Hao

P 1086. Role of PTRH2 in Cerebellar Development

Hug, Maja

FV 571. Cardiac Kids with Stroke

Hunkemöller, Franziska

FV 921. What Do Teachers Know about Epileptic Seizures or Epilepsy in School?

Huppke, Brenda

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Huppke, Peter

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

P 857. Unusual Presentation of Three Children with Alexander’s Disease and Therapy with Steroids

Husain, Ralf

FV 188. Morbus Krabbe: One disease—Two Faces

P 366. 7q11.23 Microduplication Syndrome: Neurophysiological and Neuroradiological Insights into a Rare Chromosomal Disorder

Hustedt, Ulf

FV 1016. Antibodies against Neurofascin Are Associated with Severe und Chronic Forms of Guillain–Barré’s Syndrome

Iorio, Raffaele

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Isenber, Mara

FV 1119. Incidence of Epilepsies and Epileptic Syndromes in Children and Adolescents: A Prospective Study in Göttingen, Germany in 2014

Jack, Thomas

P 411. GNAO1-Associated Hyperkinetic-Dystonic Movement Disorder and Developmental Delay in a 14-Year-Old Girl

Jacobs, Julia

FV 269. Cannabidiol for Treatment of Childhood Epilepsy—A Cross-Sectional Survey

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Jacobs-Le Van, Julia

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

Jacoby, David

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Janisch, Maria

FV 871. Pediatric Palliative Care of Duchenne Muscular Dystrophy in Germany

Jaster, Monika

P 468. Clinical Phenotype of Cerebral Palsy Depending on the Cause

Jensen, Beate

FV 837. Early Withdrawal of Antiepileptic Medication in Patients with Juvenile Myoclonic Epilepsy Is Justifiable!

FV 921. What Do Teachers Know about Epileptic Seizures or Epilepsy in School?

FV 1178. The More the Merrier? Diagnostic Yield of EEG after the First Unprovoked Seizure

P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy

P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Johannsen, Jessika

P 960. Intrathecal Administration of Nusinersen in Patients with SMA: Experience and Challenges—A Single-Center Report

P 1147. Pyridostigmine Leads to Relevant Improvement of Motor Function in an Infant with RYR1-Related Congenital Myopathy

John, Magdalena

P 1086. Role of PTRH2 in Cerebellar Development

Jones, David

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

Jung, Nikolai

FV 1031. Whole Exome Sequencing for Children with Dyskinetic Movement Disorder

P 232. Interdisciplinary Consensus on Prevention and Therapy of Hip Lateralization in Patients with Cerebral Palsy

FV 588. Probing Homeostatic and Metaplastic Mechanisms of Synaptic Plasticity in Human Primary Motor Cortex Using High-Frequent Quadri-pulse Theta Burst Stimulation

FV 776. sEMG Biofeedback Therapy in Children with Cerebral Palsy

Jung, Susan

FV 1091. C1-esterase Inhibitor Treatment Prevents Blood–Brain Barrier Dysfunction in the Neonatal Mouse Brain after Acute Systemic Hypoxia

Kaindl, Angela

FV 563. Frequency and Relevance of Neuronal Autoantibodies in Childhood Neurological Disorders

P 451. Clinical Presentation of Children and Adolescents with Neurofibromatosis Type I

Kaindl, Angela M.

FV 757. Clinical, Radiological and Genetic Spectrum of a Large Pediatric Cohort with Epilepsy

P 306. Role of Cdk5rap2 in Neocortical Development

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 468. Clinical Phenotype of Cerebral Palsy Depending on the Cause

P 1086. Role of PTRH2 in Cerebellar Development

P 973. Case Report of a 13-Year-Old Boy with Multiple Sclerosis and Obesity Caused by a MC4-Receptor Mutation

P 648. The Influence of Secondary Untethering on Bladder Function of Spina Bifida Patients

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

P 773. Standard Values for Cranial Magnetic Resonance Imaging in the First Year of Life

Kaiser, Ann-Sophie

P 694. TRIP12 Variants as a Cause of Mental Disability with or without Autism

Kalbe, Elke

FV 658. Cognitive Impairment, Depression, Fatigue, and Quality of Life in Pediatric-Onset Multiple Sclerosis: Results of the Multiple Sclerosis Inventory of Cognition in ADOlescents Study

Kalyvas, C.

IP 467. Botulinum Toxin Type A in the Management of Spasticity in Children—A Systematic Literature Review and Bayesian Network Meta-analysis

Kampmann, Christoph

P 1106. Involvement of the Cardial Autonomous Nervous System in Mitochondrial Neurogastrointestinal Encephalopathy Syndrome

Kansu, Aydan

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Kappert, Günther

P 736. Benign Enlargement of Subarachnideal Spaces and Subdural Hematoma in an Infant: Spontaneous Bleeding, Child Abuse, or Bleeding Disorder?

Kappl, Simon

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

Karabis, A.

IP 467. Botulinum Toxin Type A in the Management of Spasticity in Children—A Systematic Literature Review and Bayesian Network Meta-analysis

Karenfort, Michael

FV 1016. Antibodies against Neurofascin Are Associated with Severe und Chronic Forms of Guillain–Barré’s Syndrome

P 1168. Management of Highly Active MS in Children: Successful Early Escalation Therapy with Alemtuzumab

Kaspar, Brian K.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Kehrer, Christiane

FV 300. Living with Severe Rare Chronic Neurological Disease in Childhood: Family Burden and Quality of Life in Families with MLD and PCH2

FV 188. Morbus Krabbe: One disease—Two Faces

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Kehrer, Martin

FV 449. Cerebral Blood Flow Volume and Gray Matter Volume across a Wide Age Range

Kersting, Mathilde

P 235. Short-Term Effects of Lunch with Varying Glycemic Index on Children’s Cognitive Function—CogniDo GI-II

Kessler, Josef

FV 658. Cognitive Impairment, Depression, Fatigue, and Quality of Life in Pediatric-Onset Multiple Sclerosis: Results of the Multiple Sclerosis Inventory of Cognition in ADOlescents Study

Khan, Nadia

FV 820. Pediatric Moyamoya Angiopathy: A Rapid Progressive Disease in Children < 5 Years of Age

Kiefer, Petra

FV 953. Parents’ Experiences during the Compassionate Use Program (Nusinersen) for Patients with Spinal Muscular Atrophy Type 1—A Qualitative Interview Study

Kiening, Karl

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

Kieslich, Matthias

P 1092. The Challenging Nature of Cerebral TBC Manifestations in Children and Young Adults

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

P 587. Osmotic Myelinolysis—A Rare but Severe Complication of Diabetic Ketoacidosis

Kiess, Wieland

FV 918. How Do Pediatricians and General Practitioners Deal with Epilepsy Patients? Results of a Structured Interview

Kirschner, Janbernd

FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire

FV 953. Parents’ Experiences during the Compassionate Use Program (Nusinersen) for Patients with Spinal Muscular Atrophy Type 1—A Qualitative Interview Study

P 898. SMArtCARE: Longitudinal Data Collection of Patients with Spinal Muscular Atrophy in German-Speaking Countries

P 900. Decision Making Regarding Ventilator Support in Children with SMA type 1—A Cross-sectional Survey among German Physicians

Kissel, John T.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Kiwull, Lorenz

P 1152. Assessment of Therapeutically Guided Serious Gaming from the Point of View of the Treated Children and Adolescents—A Pilot Study

Klabunde-Cherwon, Annick

P 605. Epileptic Encephalopathy Caused by Mitochondrial MPC-1 Deficiency Can Benefit from Ketogenic Diet—Significance of Early Genetic Testing for a Targeted Therapy

Klepper, Jörg

FV 330. Have We Done Wrong? Long-Term Follow-up of Cardiovascular Risk Factors in Glut1-Deficiency Treated with Ketogenic Diet Therapies

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

FV 236. Twenty-five Years Glut1 Deficiency in Neuropediatrics—The Importance for Adult Neurology

Klose, Uwe

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Kloss, Manja

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

Kloth, Katja

P 1147. Pyridostigmine Leads to Relevant Improvement of Motor Function in an Infant with RYR1-Related Congenital Myopathy

Klotz, Alexandra

FV 269. Cannabidiol for Treatment of Childhood Epilepsy—A Cross-Sectional Survey

Kluger, Gerhard

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Knieling, Ferdinand

P 1014. Neurodevelopmental Outcome in VLWB Preterm Infants with Neonatal Seizures Born between 2008 and 2011 at the Age of 2 Years

Knieriem, Ellen

P 334. Severe Leigh-like Phenotype in an Girl with Homozygous p.Q139* Mutation in C12orf65

Knierim, Ellen

FV 563. Frequency and Relevance of Neuronal Autoantibodies in Childhood Neurological Disorders

P 973. Case Report of a 13-Year-Old Boy with Multiple Sclerosis and Obesity Caused by a MC4-Receptor Mutation

P 328. Novel Homozygous Variants Confirm SPTBN4-Related Congenital Myopathy and Expand the Clinical Phenotype

Knuf, Markus

P 1106. Involvement of the Cardial Autonomous Nervous System in Mitochondrial Neurogastrointestinal Encephalopathy Syndrome

Kochan, Aleksandra

FV 757. Clinical, Radiological and Genetic Spectrum of a Large Pediatric Cohort with Epilepsy

Koch-Hogrebe, Margret

P 1151. A 19-Month-Old Boy with Mild Epileptic Encephalopathy and Mutation in the SZT2 Gene

Köhler, Cornelia

P 1032. Cognitive Development in Children with Rolandic Epilepsy or Rolandic EEG Pattern—Preliminary Results of a Prospective Follow-up Study

P 564. Psychosocial Surrounding as an Important Influencing Factor with Hereditary Sensory and Autonomic Neuropathy—Two Case Reports

P 326. Developments in Stem Cell Transplantation in Lysosomal Storage Diseases—An Update on the Example of Mucopolysaccharidoses

Köhler, Jutta

P 328. Novel Homozygous Variants Confirm SPTBN4-Related Congenital Myopathy and Expand the Clinical Phenotype

Koitschev, Assen

P 1139. Gradenigo’s Syndrome: Two New Case Studies

Kölbel, Heike

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

P 409. The Noonan’s Syndrome as a Differential Diagnosis of a Congenital Myasthenic Syndrome

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Kölker, Stefan

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

P 781. A Cross-sectional Quantitative Analysis of the Natural History of Farber Disease: An Ultra-Orphan Condition with Rheumatologic and Neurological Cardinal Disease Features

P 605. Epileptic Encephalopathy Caused by Mitochondrial MPC-1 Deficiency Can Benefit from Ketogenic Diet—Significance of Early Genetic Testing for a Targeted Therapy

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

P 694. TRIP12 Variants as a Cause of Mental Disability with or without Autism

P 705. Axenfeld-Rieger Anomaly and Neuropsychiatric Symptoms

P 780. Misdiagnosis of Child Abuse—Fibrodysplasia Ossificans Progressiva as a Therapy-Relevant Differential Diagnosis in Infancy

Korenke, Georg-Christoph

FV 205. Parkinsonism after Coxsackievirus B3 Brain Stem Encephalitis

Kotzaeridou, Urania

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Kovacs-Nagy, Reka

P 233. Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder

Kowald, Tobias

FV 205. Parkinsonism after Coxsackievirus B3 Brain Stem Encephalitis

Koy, Anne

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

P 613. IQSEC2-Associated X-Coupled Mental Retardation 1 in a Girl with Difficult-to-Treat Epilepsy

Kraemer, Nadine

P 306. Role of Cdk5rap2 in Neocortical Development

Krägeloh-Mann, Ingeborg

P 968. Vitamine B6-Dependent Epilepsy in a 14-Year-Old Girl with Drug-Resistant Seizures and Recurring Status Epilepticus

FV 300. Living with Severe Rare Chronic Neurological Disease in Childhood: Family Burden and Quality of Life in Families with MLD and PCH2

FV 188. Morbus Krabbe: One disease—Two Faces

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Krämer, Nadine

P 1086. Role of PTRH2 in Cerebellar Development

Kranz, Katharina

P 326. Developments in Stem Cell Transplantation in Lysosomal Storage Diseases—An Update on the Example of Mucopolysaccharidoses

Kraus, Verena

P 1079. Early Diagnosis of Neuromyelitis Optica Spectrum Disease as a Prerequisite for Optimal Therapy Management—Report of a Case

Krause, Gudrun

P 1011. Think Unusual—Developmental Delay Plus: Multimodal Diagnosis of Menkes’ Syndrome

Krauspe, Rüdiger

P 232. Interdisciplinary Consensus on Prevention and Therapy of Hip Lateralization in Patients with Cerebral Palsy

Krenn, Larissa

P 788. MOG-Ab Positive Acute Disseminated Encephalomyelitis with Asymmetric Lesions in Basal Ganglia and in Thalami

Krieg, Sarah

FV 188. Morbus Krabbe: One disease—Two Faces

Kriegesmann-Loke, Antje

P 556. Ketogenic Dietary Therapies—Retrospective Assessment of 143 Children Treated at the Bethel Epilepsy Center from 2003 to 2016

Krois-Neudenberger, Jana

FV 837. Early Withdrawal of Antiepileptic Medication in Patients with Juvenile Myoclonic Epilepsy Is Justifiable!

Kröll-Seger, Judith

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Krusen, Martina

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Küchler, Alma

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Kudernatsch, Manfred

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

Kühle, Hans-Jürgen

P 327. Is Video-Assisted Methylphenidate Dose Finding for Children with ADHD a Suitable Procedure for Medical Practitioners?—Results after 4-Year-Follow-up

Kuhn, Marius

P 913. Heterozygous Nonsense Variant in the TCF20 Gene as a Cause of Congenital Myopathy

Kühn-Velten, Nikolaus

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Kuloğlu, Zarife

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Kurlemann, Gerhard

FV 837. Early Withdrawal of Antiepileptic Medication in Patients with Juvenile Myoclonic Epilepsy Is Justifiable!

FV 921. What Do Teachers Know about Epileptic Seizures or Epilepsy in School?

FV 1178. The More the Merrier? Diagnostic Yield of EEG after the First Unprovoked Seizure

P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy

P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Kurnik, Karin

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Kutschke, Georg

P 1106. Involvement of the Cardial Autonomous Nervous System in Mitochondrial Neurogastrointestinal Encephalopathy Syndrome

Lagae, Lieven

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Landgraf, Mirjam N.

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Langer, Claudia

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

Langer, Thorsten

FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire

FV 953. Parents’ Experiences during the Compassionate Use Program (Nusinersen) for Patients with Spinal Muscular Atrophy Type 1—A Qualitative Interview Study

P 900. Decision Making Regarding Ventilator Support in Children with SMA type 1—A Cross-sectional Survey among German Physicians

Latal, Bea

P 233. Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder

Laugwitz, Lucia

FV 943. Facilitating a Molecular Diagnosis as Soon as Possible: Diagnostic Exome in Neurometabolic Disorders

Laux, Linda

IP 110. Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet’s Syndrome: Results of an Open-Label Extension Trial (GWPCARE5)

Lebek, Susanne

P 882. Four-Level Release (Rideau) and Glucocorticoid Therapy in Patients with DMD—Additive Positive Effect on Ambulation

Lechner, Christian

P 855. Epidemiology of Neuromyelitis Optica Spectrum Disorders in Children and Adolescents

Lehbrink, Ruth

P 1011. Think Unusual—Developmental Delay Plus: Multimodal Diagnosis of Menkes’ Syndrome

Leiendecker, Bärbel

FV 330. Have We Done Wrong? Long-Term Follow-up of Cardiovascular Risk Factors in Glut1-Deficiency Treated with Ketogenic Diet Therapies

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Leis, Thomas

P 1081. PTEN-Associated Macrocephaly in a 3-Year-Old Girl

Leiz, Steffen

P 857. Unusual Presentation of Three Children with Alexander’s Disease and Therapy with Steroids

Lekaditi, Dimitra

FV 183. Comparison of the Early Auditory Evoked Potentials during the First Month of Life in Term and Preterm Children

FV 513. A Potential Risk of Inadequate Prognosis in Hypothermic Children after Asphyxia with Delayed Abnormalities in Diffusion-Weighted Images

Lemke, Johannes

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

Lenz, Dominic

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Leppich, Katalin

P 451. Clinical Presentation of Children and Adolescents with Neurofibromatosis Type I

Leypoldt, Frank

FV 1016. Antibodies against Neurofascin Are Associated with Severe und Chronic Forms of Guillain–Barré’s Syndrome

Lidzba, Karen

FV 695. Does Early Postnatal hCMV Infection Have Long-Term Consequences on Brain Structure of Former Preterm Born Children?

FV 930. Reduced Structural Connectivity in Nonmotor Networks in Children Born Preterm

Liehr, Thomas

P 366. 7q11.23 Microduplication Syndrome: Neurophysiological and Neuroradiological Insights into a Rare Chromosomal Disorder

Likhite, Shibi

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Lindner, Martin

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Lingnau, Anja

P 648. The Influence of Secondary Untethering on Bladder Function of Spina Bifida Patients

Lischetzki, Grischa

P 1155. Focal Epilepsy Difficult to Treat in Hermann–Pallister’s Syndrome (KBG Syndrome)

Lochmüller, Hanns

P 898. SMArtCARE: Longitudinal Data Collection of Patients with Spinal Muscular Atrophy in German-Speaking Countries

Lock, Michael

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Lowes, Linda P.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Lücke, Thomas

P 235. Short-Term Effects of Lunch with Varying Glycemic Index on Children’s Cognitive Function—CogniDo GI-II

P 1032. Cognitive Development in Children with Rolandic Epilepsy or Rolandic EEG Pattern—Preliminary Results of a Prospective Follow-up Study

FV 969. Transplantation Surgery Used Autologous Transgenic Keratinocyte Cultures Which Regenerated an Entire, Fully Functional Epidermis

P 329. Patients with Juvenile Huntington’s Disease Benefit from Early Diagnosis

P 564. Psychosocial Surrounding as an Important Influencing Factor with Hereditary Sensory and Autonomic Neuropathy—Two Case Reports

P 326. Developments in Stem Cell Transplantation in Lysosomal Storage Diseases—An Update on the Example of Mucopolysaccharidoses

P 736. Benign Enlargement of Subarachnideal Spaces and Subdural Hematoma in an Infant: Spontaneous Bleeding, Child Abuse, or Bleeding Disorder?

Luedecke, Hermann Josef

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

Luperi, Ilaria

P 1086. Role of PTRH2 in Cerebellar Development

Lüsebrink, Natalia

P 587. Osmotic Myelinolysis—A Rare but Severe Complication of Diabetic Ketoacidosis

Lütschg, Jürg

FV 113. Electrophysiological Diagnostic of Neuromuscular Diseases in Newborns, Infants, and Toddlers

Lutz, Thomas

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

L’italien, James

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Magg, Janine

P 968. Vitamine B6-Dependent Epilepsy in a 14-Year-Old Girl with Drug-Resistant Seizures and Recurring Status Epilepticus

Maier, Esther M.

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Maier, Oliver

FV 183. Comparison of the Early Auditory Evoked Potentials during the First Month of Life in Term and Preterm Children

FV 113. Electrophysiological Diagnostic of Neuromuscular Diseases in Newborns, Infants, and Toddlers

P 1166. Isolated Oculomotor Nerve Palsy as Primary Manifestation of Guillain–Barré’s Syndrome—A Case Report with Focus on Clinical and Electrophysiological Features

Maier, Ursula

P 1151. A 19-Month-Old Boy with Mild Epileptic Encephalopathy and Mutation in the SZT2 Gene

Makowski, Christine

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

P 1079. Early Diagnosis of Neuromyelitis Optica Spectrum Disease as a Prerequisite for Optimal Therapy Management—Report of a Case

Mall, Volker

FV 1031. Whole Exome Sequencing for Children with Dyskinetic Movement Disorder

FV 658. Cognitive Impairment, Depression, Fatigue, and Quality of Life in Pediatric-Onset Multiple Sclerosis: Results of the Multiple Sclerosis Inventory of Cognition in ADOlescents Study

P 232. Interdisciplinary Consensus on Prevention and Therapy of Hip Lateralization in Patients with Cerebral Palsy

FV 588. Probing Homeostatic and Metaplastic Mechanisms of Synaptic Plasticity in Human Primary Motor Cortex Using High-Frequent Quadri-pulse Theta Burst Stimulation

FV 776. sEMG Biofeedback Therapy in Children with Cerebral Palsy

FV 798. Neurofeedback Therapy for ADDH: Training with z-scored QEEG-Frequency Bands

P 1079. Early Diagnosis of Neuromyelitis Optica Spectrum Disease as a Prerequisite for Optimal Therapy Management—Report of a Case

Mammadova, Dilbar

P 1008. Neuronal Migration Disorders in Infants with 22q11.2 Deletion Syndrome—Two Case Reports

Mangold, Elisabeth

P 1001. A Pathogenic GABRB3 Variant Is Associated with Cleft Palate in a Patient with Epileptic Encephalopathy

Marina, Adela Della

FV 330. Have We Done Wrong? Long-Term Follow-up of Cardiovascular Risk Factors in Glut1-Deficiency Treated with Ketogenic Diet Therapies

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

P 409. The Noonan’s Syndrome as a Differential Diagnosis of a Congenital Myasthenic Syndrome

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Marquard, Klaus

P 1139. Gradenigo’s Syndrome: Two New Case Studies

Marquardt, Iris

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

P 366. 7q11.23 Microduplication Syndrome: Neurophysiological and Neuroradiological Insights into a Rare Chromosomal Disorder

Marquardt, Thorsten

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Martakis, Kyriakos

P 613. IQSEC2-Associated X-Coupled Mental Retardation 1 in a Girl with Difficult-to-Treat Epilepsy

Mayer, Thomas

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Mcclean, Patricia

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Meier-Sprinz, Brigitte

P 1097. How Do Parents Experience Music Therapy during Neuropediatric Early Rehabilitation?—A Qualitative Pilot Study

Meitinger, Thomas

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

P 913. Heterozygous Nonsense Variant in the TCF20 Gene as a Cause of Congenital Myopathy

Mendell, Jerry R.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Mengershausen, Ursula von

P 1166. Isolated Oculomotor Nerve Palsy as Primary Manifestation of Guillain–Barré’s Syndrome—A Case Report with Focus on Clinical and Electrophysiological Features

Mengler, Katharina

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Mérat, Michèle

FV 513. A Potential Risk of Inadequate Prognosis in Hypothermic Children after Asphyxia with Delayed Abnormalities in Diffusion-Weighted Images

Merkenschlager, Andreas

FV 918. How Do Pediatricians and General Practitioners Deal with Epilepsy Patients? Results of a Structured Interview

P 705. Axenfeld-Rieger Anomaly and Neuropsychiatric Symptoms

Metz, Charlotte

P 468. Clinical Phenotype of Cerebral Palsy Depending on the Cause

Meyer, Kathrin

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Millan, Francisca

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Miller, Ian

IP 110. Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet’s Syndrome: Results of an Open-Label Extension Trial (GWPCARE5)

Mink, Jonathan W.

FV 1180. The Unified Batten Disease Rating Scale: An International Collaboration Testing Validation and Reliability in an Independent Cohort of CLN3-Patients

Mistry, Arun

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Mohr, Naomi

P 773. Standard Values for Cranial Magnetic Resonance Imaging in the First Year of Life

Morrison, Glenn

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Mühlhausen, Chris

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Müller, Cornelia K.

FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire

Müller, Michael

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Müller-Felber, Wolfgang

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

P 913. Heterozygous Nonsense Variant in the TCF20 Gene as a Cause of Congenital Myopathy

Müller-Koch, Yvonne

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Nabbout, Rima

IP 110. Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet’s Syndrome: Results of an Open-Label Extension Trial (GWPCARE5)

Nägele, Thomas

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Nagendran, Sukumar

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Näke, Andrea

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Neininger, Martina P.

FV 918. How Do Pediatricians and General Practitioners Deal with Epilepsy Patients? Results of a Structured Interview

Neubauer, Bernd

FV 510. Influence of Anticonvulsive Treatment on the EEG and the Neuropsychological Features in Children with Rolandic Epilepsy

Neuhann, Teresa

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Neuhäuser, Gerhard

P 327. Is Video-Assisted Methylphenidate Dose Finding for Children with ADHD a Suitable Procedure for Medical Practitioners?—Results after 4-Year-Follow-up

Neumann, Helmut

P 1032. Cognitive Development in Children with Rolandic Epilepsy or Rolandic EEG Pattern—Preliminary Results of a Prospective Follow-up Study

Nickel, Miriam

FV 1180. The Unified Batten Disease Rating Scale: An International Collaboration Testing Validation and Reliability in an Independent Cohort of CLN3-Patients

FV 1182. Ataxia and/or Language Regression at Early School Age—Think of Atypical CLN2 Disease

FV 1181. Intracerebroventricular Drug Delivery for CLN2 Disease—5 Years of Experience with ICV Enzyme Replacement Therapy in Hamburg

Nicolai, Thomas

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

Niederstadt, Thomas

P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy

P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Niemeyer, Antje

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

Nikkhah, Guido

P 1139. Gradenigo’s Syndrome: Two New Case Studies

Nikolaus, Marc

FV 563. Frequency and Relevance of Neuronal Autoantibodies in Childhood Neurological Disorders

Nolte-Buchholtz, Silke

FV 871. Pediatric Palliative Care of Duchenne Muscular Dystrophy in Germany

Noßwitz, Ulrike

P 1151. A 19-Month-Old Boy with Mild Epileptic Encephalopathy and Mutation in the SZT2 Gene

Nürnberg, Peter

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

O´callaghan, Finbar J

FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience

Och, Ulrike

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Ohlenschläger, Ute

P 587. Osmotic Myelinolysis—A Rare but Severe Complication of Diabetic Ketoacidosis

Olivieri, Martin

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Omran, Heymut

FV 1177. Genetic Causes of Congenital Hydrocephalus

P 967. IRIS—A Dreaded Complication of Tuberculous Meningitis

Ortfeld, Stefan

FV 1170. What Influences Motor Function in VLBW Preterm at 5 Years of Age?

Osinski, Daniela

P 1081. PTEN-Associated Macrocephaly in a 3-Year-Old Girl

P 1008. Neuronal Migration Disorders in Infants with 22q11.2 Deletion Syndrome—Two Case Reports

P 1077. Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation (LBSL): A Case Report

Panzer, Axel

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Pargac, Kai-Nils

P 518. Vitamin B6-Dependent West’s Syndrome: An Unexplained Case

Pauls, Amande

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

Pechmann, Astrid

FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire

FV 953. Parents’ Experiences during the Compassionate Use Program (Nusinersen) for Patients with Spinal Muscular Atrophy Type 1—A Qualitative Interview Study

P 898. SMArtCARE: Longitudinal Data Collection of Patients with Spinal Muscular Atrophy in German-Speaking Countries

P 900. Decision Making Regarding Ventilator Support in Children with SMA type 1—A Cross-sectional Survey among German Physicians

Penning, Jeff

P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy

P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Peraud, Aurelia

FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience

Perez, Marie-Hélène

FV 571. Cardiac Kids with Stroke

Pergande, Matthias

P 1001. A Pathogenic GABRB3 Variant Is Associated with Cleft Palate in a Patient with Epileptic Encephalopathy

Persits, Sergey

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

Peterli, Judith

FV 183. Comparison of the Early Auditory Evoked Potentials during the First Month of Life in Term and Preterm Children

Petermann, Franz

P 1032. Cognitive Development in Children with Rolandic Epilepsy or Rolandic EEG Pattern—Preliminary Results of a Prospective Follow-up Study

Pfammatter, Jean-Pierre

FV 571. Cardiac Kids with Stroke

Pfister, Stefan

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

Pfurtscheller, Klaus

P 788. MOG-Ab Positive Acute Disseminated Encephalomyelitis with Asymmetric Lesions in Basal Ganglia and in Thalami

Picker-Minh, Sylvie

P 1086. Role of PTRH2 in Cerebellar Development

Plecko, Barbara

P 788. MOG-Ab Positive Acute Disseminated Encephalomyelitis with Asymmetric Lesions in Basal Ganglia and in Thalami

Plecko-Startinig, Barbara

FV 735. UBTF-Related Dementia and Parkinsonism—Case Report of a Novel Disease Entity

P 1030. MRI Pattern in Neurodegeneration with Brain Iron Accumulation and Fucosidosis Appear Similar

Poggenburg, Imke

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Polster, Tilman

P 556. Ketogenic Dietary Therapies—Retrospective Assessment of 143 Children Treated at the Bethel Epilepsy Center from 2003 to 2016

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Porto, Luciana

P 1092. The Challenging Nature of Cerebral TBC Manifestations in Children and Young Adults

Posingies, Ralph

FV 921. What Do Teachers Know about Epileptic Seizures or Epilepsy in School?

Potratz, Cornelia

P 451. Clinical Presentation of Children and Adolescents with Neurofibromatosis Type I

Pozza, Robert Dalla

FV 330. Have We Done Wrong? Long-Term Follow-up of Cardiovascular Risk Factors in Glut1-Deficiency Treated with Ketogenic Diet Therapies

Prager, Christine

FV 757. Clinical, Radiological and Genetic Spectrum of a Large Pediatric Cohort with Epilepsy

P 1098. Intravenous Nimodipine Ameliorating an Episode of Sporadic Hemiplegic Migraine with Prolonged Hemiplegia and Severe Disturbances of Cognition

Pretzel, Pablo

FV 930. Reduced Structural Connectivity in Nonmotor Networks in Children Born Preterm

Pringsheim, Milka

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Prior, Thomas W.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Privitera, Michael

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

Prokisch, Holger

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

P 605. Epileptic Encephalopathy Caused by Mitochondrial MPC-1 Deficiency Can Benefit from Ketogenic Diet—Significance of Early Genetic Testing for a Targeted Therapy

Promnitz, Gabriel

P 773. Standard Values for Cranial Magnetic Resonance Imaging in the First Year of Life

Rabenau, Holger

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

Ranucci, Giusy

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Rauh, M.

FV 1091. C1-esterase Inhibitor Treatment Prevents Blood–Brain Barrier Dysfunction in the Neonatal Mouse Brain after Acute Systemic Hypoxia

Redyk, Katharina

FV 205. Parkinsonism after Coxsackievirus B3 Brain Stem Encephalitis

Regényi, Mária

FV 571. Cardiac Kids with Stroke

Reihle, Christof

P 1139. Gradenigo’s Syndrome: Two New Case Studies

Reindl, Markus

FV 1016. Antibodies against Neurofascin Are Associated with Severe und Chronic Forms of Guillain–Barré’s Syndrome

P 855. Epidemiology of Neuromyelitis Optica Spectrum Disorders in Children and Adolescents

Reinersmann, Annika

FV 969. Transplantation Surgery Used Autologous Transgenic Keratinocyte Cultures Which Regenerated an Entire, Fully Functional Epidermis

Reiter, Karl

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

Reutlinger, Constanze

FV 840. Communication Possibilities for Girls with Rett’s Syndrome

Ries, Markus

P 781. A Cross-sectional Quantitative Analysis of the Natural History of Farber Disease: An Ultra-Orphan Condition with Rheumatologic and Neurological Cardinal Disease Features

Rieß, Olaf

FV 943. Facilitating a Molecular Diagnosis as Soon as Possible: Diagnostic Exome in Neurometabolic Disorders

Rimensberger, Peter

FV 571. Cardiac Kids with Stroke

Roberts, Claire

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

IP 110. Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet’s Syndrome: Results of an Open-Label Extension Trial (GWPCARE5)

Rodino-Klapac, Louise

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Rödl, Siegfried

P 788. MOG-Ab Positive Acute Disseminated Encephalomyelitis with Asymmetric Lesions in Basal Ganglia and in Thalami

Rompel, Oliver

P 1081. PTEN-Associated Macrocephaly in a 3-Year-Old Girl

P 1077. Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation (LBSL): A Case Report

Rossler, Leo

P 736. Benign Enlargement of Subarachnideal Spaces and Subdural Hematoma in an Infant: Spontaneous Bleeding, Child Abuse, or Bleeding Disorder?

Rostasy, Kevin

FV 1016. Antibodies against Neurofascin Are Associated with Severe und Chronic Forms of Guillain–Barré’s Syndrome

P 855. Epidemiology of Neuromyelitis Optica Spectrum Disorders in Children and Adolescents

P 336. Unusual Manifestation of Lyme Neuroborreliosis in Childhood and Adolescence

P 857. Unusual Presentation of Three Children with Alexander’s Disease and Therapy with Steroids

Rostásy, Kevin

P 1151. A 19-Month-Old Boy with Mild Epileptic Encephalopathy and Mutation in the SZT2 Gene

Rothoeft, Tobias

FV 969. Transplantation Surgery Used Autologous Transgenic Keratinocyte Cultures Which Regenerated an Entire, Fully Functional Epidermis

Rupprich, Katrin

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Rüsch, Christina

P 233. Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder

Ryczek, Monika

P 451. Clinical Presentation of Children and Adolescents with Neurofibromatosis Type I

Saffari, Afshin

P 705. Axenfeld-Rieger Anomaly and Neuropsychiatric Symptoms

Saft, Carsten

P 329. Patients with Juvenile Huntington’s Disease Benefit from Early Diagnosis

Sánchez-Albisua, Iciar

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Sarpong-Bengelsdorf, Akosua

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 468. Clinical Phenotype of Cerebral Palsy Depending on the Cause

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

Schallner, Jens

P 522. Measuring Grip and Finger Flexion Strength in Children and Adolescents with Neuromuscular Disorders

P 370. Establishing Anthropometric Parameters and Strength Parameters of the Hand and Arm—Standard Values for Pediatric Neurorehabilitation

Schanda, Kathrin

P 855. Epidemiology of Neuromyelitis Optica Spectrum Disorders in Children and Adolescents

Schara, Ulrike

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

P 409. The Noonan’s Syndrome as a Differential Diagnosis of a Congenital Myasthenic Syndrome

P 898. SMArtCARE: Longitudinal Data Collection of Patients with Spinal Muscular Atrophy in German-Speaking Countries

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Schiergens, Katharina A.

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Schipper, Birgit

P 1155. Focal Epilepsy Difficult to Treat in Hermann–Pallister’s Syndrome (KBG Syndrome)

Schmid, Karoline

FV 798. Neurofeedback Therapy for ADDH: Training with z-scored QEEG-Frequency Bands

Schmid, Ulrich

FV 798. Neurofeedback Therapy for ADDH: Training with z-scored QEEG-Frequency Bands

Schmidt, Martina

P 1014. Neurodevelopmental Outcome in VLWB Preterm Infants with Neonatal Seizures Born between 2008 and 2011 at the Age of 2 Years

Schmidt, Nele Kaline

P 336. Unusual Manifestation of Lyme Neuroborreliosis in Childhood and Adolescence

Schnabel, Sabrina

FV 918. How Do Pediatricians and General Practitioners Deal with Epilepsy Patients? Results of a Structured Interview

Schneider, Joanna

FV 757. Clinical, Radiological and Genetic Spectrum of a Large Pediatric Cohort with Epilepsy

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 468. Clinical Phenotype of Cerebral Palsy Depending on the Cause

P 451. Clinical Presentation of Children and Adolescents with Neurofibromatosis Type I

P 648. The Influence of Secondary Untethering on Bladder Function of Spina Bifida Patients

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

P 773. Standard Values for Cranial Magnetic Resonance Imaging in the First Year of Life

Schnittert-Hübener, Sarah

P 973. Case Report of a 13-Year-Old Boy with Multiple Sclerosis and Obesity Caused by a MC4-Receptor Mutation

Schnur, Rhonda

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Schoening, Stefan

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

Scholl-Buergi, Sabine

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Schöne-Bake, Jan-Christoph

P 411. GNAO1-Associated Hyperkinetic-Dystonic Movement Disorder and Developmental Delay in a 14-Year-Old Girl

Schönfeld, Brigitte

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Schöning, Martin

FV 449. Cerebral Blood Flow Volume and Gray Matter Volume across a Wide Age Range

Schorling, David

FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire

Schriever, Valentin

FV 606. Untersuchungen von Riechtraining auf die olfaktorische Funktion und kognitive Leistung nach Schädel-Hirn-Trauma im Kindesalter

P 379. Objective Assessment of Central Nervous Odor Processing in Infancy

Schröder, Sebastian

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

P 913. Heterozygous Nonsense Variant in the TCF20 Gene as a Cause of Congenital Myopathy

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Schröder, Simone

FV 1118. The Acquisition of Rare Neurological Disorders in Childhood (“ESNEK”)—Interim Results after 4 Years

Schubert-Bast, Susanne

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

Schuelke, Markus

P 328. Novel Homozygous Variants Confirm SPTBN4-Related Congenital Myopathy and Expand the Clinical Phenotype

Schuler, Heike

FV 658. Cognitive Impairment, Depression, Fatigue, and Quality of Life in Pediatric-Onset Multiple Sclerosis: Results of the Multiple Sclerosis Inventory of Cognition in ADOlescents Study

Schülke, Markus

FV 563. Frequency and Relevance of Neuronal Autoantibodies in Childhood Neurological Disorders

Schülke-Gerstenfeld, Markus

P 334. Severe Leigh-like Phenotype in an Girl with Homozygous p.Q139* Mutation in C12orf65

Schultze-Rhonhof, Mira

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

Schulz, Angela

FV 1180. The Unified Batten Disease Rating Scale: An International Collaboration Testing Validation and Reliability in an Independent Cohort of CLN3-Patients

FV 1182. Ataxia and/or Language Regression at Early School Age—Think of Atypical CLN2 Disease

FV 1181. Intracerebroventricular Drug Delivery for CLN2 Disease—5 Years of Experience with ICV Enzyme Replacement Therapy in Hamburg

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Schulz, Anne

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

Schulz, Matthias

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

Schulze, Johannes

P 1092. The Challenging Nature of Cerebral TBC Manifestations in Children and Young Adults

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

Schulze-Bonhage, Andreas

FV 269. Cannabidiol for Treatment of Childhood Epilepsy—A Cross-Sectional Survey

Schulz-Heise, Susanne

P 1008. Neuronal Migration Disorders in Infants with 22q11.2 Deletion Syndrome—Two Case Reports

Schwabe, Katharina

FV 606. Untersuchungen von Riechtraining auf die olfaktorische Funktion und kognitive Leistung nach Schädel-Hirn-Trauma im Kindesalter

Schwalb, Sonja

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

Schwartz, Oliver

FV 837. Early Withdrawal of Antiepileptic Medication in Patients with Juvenile Myoclonic Epilepsy Is Justifiable!

FV 921. What Do Teachers Know about Epileptic Seizures or Epilepsy in School?

FV 1178. The More the Merrier? Diagnostic Yield of EEG after the First Unprovoked Seizure

P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy

P 967. IRIS—A Dreaded Complication of Tuberculous Meningitis

P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Schwarz, Oliver

FV 1177. Genetic Causes of Congenital Hydrocephalus

Schweiger, Bernd

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Schwering, Christoph

FV 1180. The Unified Batten Disease Rating Scale: An International Collaboration Testing Validation and Reliability in an Independent Cohort of CLN3-Patients

FV 1182. Ataxia and/or Language Regression at Early School Age—Think of Atypical CLN2 Disease

FV 1181. Intracerebroventricular Drug Delivery for CLN2 Disease—5 Years of Experience with ICV Enzyme Replacement Therapy in Hamburg

Schwerin-Nagel, Anette

P 1030. MRI Pattern in Neurodegeneration with Brain Iron Accumulation and Fucosidosis Appear Similar

Schwersenz, Inge

P 898. SMArtCARE: Longitudinal Data Collection of Patients with Spinal Muscular Atrophy in German-Speaking Countries

Seidel, Meike

FV 695. Does Early Postnatal hCMV Infection Have Long-Term Consequences on Brain Structure of Former Preterm Born Children?

Seidel, Ulrich

FV 1016. Antibodies against Neurofascin Are Associated with Severe und Chronic Forms of Guillain–Barré’s Syndrome

P 973. Case Report of a 13-Year-Old Boy with Multiple Sclerosis and Obesity Caused by a MC4-Receptor Mutation

P 648. The Influence of Secondary Untethering on Bladder Function of Spina Bifida Patients

Seidl, Rainer

FV 1016. Antibodies against Neurofascin Are Associated with Severe und Chronic Forms of Guillain–Barré’s Syndrome

Sekarski, Nicole

FV 571. Cardiac Kids with Stroke

Serino, Domenico

P 366. 7q11.23 Microduplication Syndrome: Neurophysiological and Neuroradiological Insights into a Rare Chromosomal Disorder

Shell, Richard

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Siebner, Hartwig

FV 588. Probing Homeostatic and Metaplastic Mechanisms of Synaptic Plasticity in Human Primary Motor Cortex Using High-Frequent Quadri-pulse Theta Burst Stimulation

Sinningen, Kathrin

P 235. Short-Term Effects of Lunch with Varying Glycemic Index on Children’s Cognitive Function—CogniDo GI-II

Slasor, Peter

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Slavova, Nedelina

FV 513. A Potential Risk of Inadequate Prognosis in Hypothermic Children after Asphyxia with Delayed Abnormalities in Diffusion-Weighted Images

Smith, Laurie D.

P 328. Novel Homozygous Variants Confirm SPTBN4-Related Congenital Myopathy and Expand the Clinical Phenotype

Sommerville, Kenneth

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

Sorantin, Erich

P 788. MOG-Ab Positive Acute Disseminated Encephalomyelitis with Asymmetric Lesions in Basal Ganglia and in Thalami

P 1030. MRI Pattern in Neurodegeneration with Brain Iron Accumulation and Fucosidosis Appear Similar

Specchio, Nicola

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Spiegler, Juliane

FV 1170. What Influences Motor Function in VLBW Preterm at 5 Years of Age?

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Spors, Birgit

P 773. Standard Values for Cranial Magnetic Resonance Imaging in the First Year of Life

Sproule, Douglas M.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Stahl, Anna

P 329. Patients with Juvenile Huntington’s Disease Benefit from Early Diagnosis

Stark, G. Björn

FV 947. What, When, and for Whom?—Reconstructive Surgery for Congenital Complete and Partial Facial Palsy

Stark, Wiebke

FV 1119. Incidence of Epilepsies and Epileptic Syndromes in Children and Adolescents: A Prospective Study in Göttingen, Germany in 2014

Staudt, Martin

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

Staufner, Christian

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Stein, Anja

P 307. Walker–Warburg’s Syndrome Due to Homozygous POMK Mutation in Preterm Twins: Case Report

Steinbrücker, Katja

P 1081. PTEN-Associated Macrocephaly in a 3-Year-Old Girl

Steinert, Martin

P 1032. Cognitive Development in Children with Rolandic Epilepsy or Rolandic EEG Pattern—Preliminary Results of a Prospective Follow-up Study

Steinfeld, Robert

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Steinke-Lange, Verena

P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?

Steinlin, Maja

FV 571. Cardiac Kids with Stroke

FV 513. A Potential Risk of Inadequate Prognosis in Hypothermic Children after Asphyxia with Delayed Abnormalities in Diffusion-Weighted Images

Stephani, Ulrich

P 1176. Unfamiliar Interactions of Antiepileptic Drugs

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Stettner, Georg

P 233. Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder

Stichtenoth, Guido

FV 1170. What Influences Motor Function in VLBW Preterm at 5 Years of Age?

Stoltenburg, Corinna

P 882. Four-Level Release (Rideau) and Glucocorticoid Therapy in Patients with DMD—Additive Positive Effect on Ambulation

Storck, Michael

FV 921. What Do Teachers Know about Epileptic Seizures or Epilepsy in School?

Straeter, Ronald

P 967. IRIS—A Dreaded Complication of Tuberculous Meningitis

Straub, Beate

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Strölin, Manuel

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Strom, Tim M.

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

Strotmann, Peter

P 1079. Early Diagnosis of Neuromyelitis Optica Spectrum Disease as a Prerequisite for Optimal Therapy Management—Report of a Case

Sturm, Marc

FV 943. Facilitating a Molecular Diagnosis as Soon as Possible: Diagnostic Exome in Neurometabolic Disorders

Stüve, Burkhard

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Sullivan, Joseph

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Süßmut, David

P 328. Novel Homozygous Variants Confirm SPTBN4-Related Congenital Myopathy and Expand the Clinical Phenotype

Syrbe, Steffen

P 605. Epileptic Encephalopathy Caused by Mitochondrial MPC-1 Deficiency Can Benefit from Ketogenic Diet—Significance of Early Genetic Testing for a Targeted Therapy

P 1162. Somatic Mosaics in Epileptogenic Tissue—Background and Therapeutic Implications of Molecular Changes in Structural Epilepsies

P 705. Axenfeld-Rieger Anomaly and Neuropsychiatric Symptoms

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Tacke, Moritz

FV 510. Influence of Anticonvulsive Treatment on the EEG and the Neuropsychological Features in Children with Rolandic Epilepsy

FV 257. Munich Early Recognition of Childhood Stroke—More than a FAST Screening Tool

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Tacke, Uta

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

Taylor, Robert

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Theis, Marius

P 1092. The Challenging Nature of Cerebral TBC Manifestations in Children and Young Adults

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

Thiel, Christian

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Thiele, Holger

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Thiele, Simone

FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire

Thiels, Charlotte

P 1032. Cognitive Development in Children with Rolandic Epilepsy or Rolandic EEG Pattern—Preliminary Results of a Prospective Follow-up Study

P 329. Patients with Juvenile Huntington’s Disease Benefit from Early Diagnosis

P 564. Psychosocial Surrounding as an Important Influencing Factor with Hereditary Sensory and Autonomic Neuropathy—Two Case Reports

P 326. Developments in Stem Cell Transplantation in Lysosomal Storage Diseases—An Update on the Example of Mucopolysaccharidoses

P 736. Benign Enlargement of Subarachnideal Spaces and Subdural Hematoma in an Infant: Spontaneous Bleeding, Child Abuse, or Bleeding Disorder?

Thimm, Eva

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Thomale, Ulrich-Wilhelm

P 648. The Influence of Secondary Untethering on Bladder Function of Spina Bifida Patients

Tibussek, Daniel

FV 1165. Limb Ischemia and Arterial Ischemic Stroke in a Newborn: Coincidence or Common Cause?

P 1164. Pre-wallerian Degeneration versus New Ischemic Infarction

Toelle, Sandra

P 295. Everolimus Trial for a Patient with Bannayan–Riley–Ruvalcaba’s Syndrome and Progressive Lipomatosis

Tönshoff, Burkhard

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Topf, Hg

FV 1091. C1-esterase Inhibitor Treatment Prevents Blood–Brain Barrier Dysfunction in the Neonatal Mouse Brain after Acute Systemic Hypoxia

Trollmann, R.

FV 1091. C1-esterase Inhibitor Treatment Prevents Blood–Brain Barrier Dysfunction in the Neonatal Mouse Brain after Acute Systemic Hypoxia

Trollmann, Regina

P 1081. PTEN-Associated Macrocephaly in a 3-Year-Old Girl

P 1008. Neuronal Migration Disorders in Infants with 22q11.2 Deletion Syndrome—Two Case Reports

P 1014. Neurodevelopmental Outcome in VLWB Preterm Infants with Neonatal Seizures Born between 2008 and 2011 at the Age of 2 Years

P 1077. Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation (LBSL): A Case Report

Ulreich, Raphael

P 788. MOG-Ab Positive Acute Disseminated Encephalomyelitis with Asymmetric Lesions in Basal Ganglia and in Thalami

Ungerath, Kristina

P 1155. Focal Epilepsy Difficult to Treat in Hermann–Pallister’s Syndrome (KBG Syndrome)

Valova, Valeria

FV 757. Clinical, Radiological and Genetic Spectrum of a Large Pediatric Cohort with Epilepsy

van's Gravesande, Karin Storm

FV 658. Cognitive Impairment, Depression, Fatigue, and Quality of Life in Pediatric-Onset Multiple Sclerosis: Results of the Multiple Sclerosis Inventory of Cognition in ADOlescents Study

van Riesen, Anne

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

Vill, Katharina

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

P 913. Heterozygous Nonsense Variant in the TCF20 Gene as a Cause of Congenital Myopathy

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Vogler, Lukas

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

von der Hagen, Maja

P 916. Lissencephaly and Prolonged Survival of a Male Infant with MICPCH and a Noval Mutation in the CASK Gene, Xp11.4

FV 871. Pediatric Palliative Care of Duchenne Muscular Dystrophy in Germany

FV 606. Untersuchungen von Riechtraining auf die olfaktorische Funktion und kognitive Leistung nach Schädel-Hirn-Trauma im Kindesalter

P 522. Measuring Grip and Finger Flexion Strength in Children and Adolescents with Neuromuscular Disorders

P 370. Establishing Anthropometric Parameters and Strength Parameters of the Hand and Arm—Standard Values for Pediatric Neurorehabilitation

P 379. Objective Assessment of Central Nervous Odor Processing in Infancy

von Kalle, Thekla

P 1139. Gradenigo’s Syndrome: Two New Case Studies

von Kries, Rüdiger

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Von Spiczak, Sarah

P 1176. Unfamiliar Interactions of Antiepileptic Drugs

von Stüpnagel, Celina

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Vossbeck, Judith

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Wacker, Ute

P 1176. Unfamiliar Interactions of Antiepileptic Drugs

Wagner, Matias

FV 1031. Whole Exome Sequencing for Children with Dyskinetic Movement Disorder

P 913. Heterozygous Nonsense Variant in the TCF20 Gene as a Cause of Congenital Myopathy

Walch, Elisabeth

P 468. Clinical Phenotype of Cerebral Palsy Depending on the Cause

Wallmeier, Julia

FV 1177. Genetic Causes of Congenital Hydrocephalus

Walsh, Sonja

P 916. Lissencephaly and Prolonged Survival of a Male Infant with MICPCH and a Noval Mutation in the CASK Gene, Xp11.4

Walter, Maggie C.

FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire

P 898. SMArtCARE: Longitudinal Data Collection of Patients with Spinal Muscular Atrophy in German-Speaking Countries

Walther, Frank

P 1011. Think Unusual—Developmental Delay Plus: Multimodal Diagnosis of Menkes’ Syndrome

Warthemann, Rita

FV 1118. The Acquisition of Rare Neurological Disorders in Childhood (“ESNEK”)—Interim Results after 4 Years

Weber, Constanze

P 522. Measuring Grip and Finger Flexion Strength in Children and Adolescents with Neuromuscular Disorders

P 370. Establishing Anthropometric Parameters and Strength Parameters of the Hand and Arm—Standard Values for Pediatric Neurorehabilitation

Weber, Hansjörg

P 522. Measuring Grip and Finger Flexion Strength in Children and Adolescents with Neuromuscular Disorders

P 370. Establishing Anthropometric Parameters and Strength Parameters of the Hand and Arm—Standard Values for Pediatric Neurorehabilitation

Wegener-Panzer, Andreas

P 336. Unusual Manifestation of Lyme Neuroborreliosis in Childhood and Adolescence

P 857. Unusual Presentation of Three Children with Alexander’s Disease and Therapy with Steroids

Weichselbaum, Annette

P 968. Vitamine B6-Dependent Epilepsy in a 14-Year-Old Girl with Drug-Resistant Seizures and Recurring Status Epilepticus

Weijers, L

IP 467. Botulinum Toxin Type A in the Management of Spasticity in Children—A Systematic Literature Review and Bayesian Network Meta-analysis

Weinberger, Raphael

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

FV 396. Childhood Hemorrhagic Stroke—A 7-Year Single-Center Experience

FV 561. Childhood Stroke: Awareness, Interest and Knowledge among the Pediatric Community

FV 394. Childhood Arterial Ischaemic Stroke—Results of a German Nationwide Surveillance Study 2015 to 2017

Weinhold, Natalie

FV 754. Newborn Screening, a Disease-Modifying Intervention for Glutaric Aciduria Type 1

Weise, Dagmar

FV 1119. Incidence of Epilepsies and Epileptic Syndromes in Children and Adolescents: A Prospective Study in Göttingen, Germany in 2014

Weisflog, Anna-Monika

P 1014. Neurodevelopmental Outcome in VLWB Preterm Infants with Neonatal Seizures Born between 2008 and 2011 at the Age of 2 Years

Weiss, Deike

P 960. Intrathecal Administration of Nusinersen in Patients with SMA: Experience and Challenges—A Single-Center Report

Weiss, Jakob

FV 947. What, When, and for Whom?—Reconstructive Surgery for Congenital Complete and Partial Facial Palsy

Weiß, Claudia

P 882. Four-Level Release (Rideau) and Glucocorticoid Therapy in Patients with DMD—Additive Positive Effect on Ambulation

Weissbach, Susann

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Wells, Courtney

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Wenning, Daniel

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Werry, Bianca

FV 757. Clinical, Radiological and Genetic Spectrum of a Large Pediatric Cohort with Epilepsy

Westhoff, Bettina

P 232. Interdisciplinary Consensus on Prevention and Therapy of Hip Lateralization in Patients with Cerebral Palsy

Wibbeler, Eva

FV 1180. The Unified Batten Disease Rating Scale: An International Collaboration Testing Validation and Reliability in an Independent Cohort of CLN3-Patients

FV 1182. Ataxia and/or Language Regression at Early School Age—Think of Atypical CLN2 Disease

FV 1181. Intracerebroventricular Drug Delivery for CLN2 Disease—5 Years of Experience with ICV Enzyme Replacement Therapy in Hamburg

Wieczorek, Dagmar

P 308. Autosomal Recessive Mutations in the NALCN Gene: A Rare Cause of a Severe Developmental Disorder with Facial Dysmorphia, Epilepsy and Cheyne–Stokes/Biot’s Respiration with Central Apneas

Wiemer-Kruel, Adelheid

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Wiethoff-Ubrig, Lucia

P 1151. A 19-Month-Old Boy with Mild Epileptic Encephalopathy and Mutation in the SZT2 Gene

Wilke, Marko

FV 449. Cerebral Blood Flow Volume and Gray Matter Volume across a Wide Age Range

FV 695. Does Early Postnatal hCMV Infection Have Long-Term Consequences on Brain Structure of Former Preterm Born Children?

FV 930. Reduced Structural Connectivity in Nonmotor Networks in Children Born Preterm

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Wille, David-Alexander

FV 735. UBTF-Related Dementia and Parkinsonism—Case Report of a Novel Disease Entity

Winkelmann, Juliane

FV 1031. Whole Exome Sequencing for Children with Dyskinetic Movement Disorder

Winkler, Peter

P 1171. Cervical Decompression due to Progressive Cervical Myelopathy in Children after Shunt Treatment of Neonatal E. coli Meningitis

Wirrell, Elaine C

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

Wittmack, Elisa

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

Wohlrab, Gabriele

P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Wolf, Annika

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Wolf, Nicole

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Wolff, Markus

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Wolter, Simone

P 980. Selective Motor Control Improves after Selective Dorsal Rhizotomy

P 1175. Increased Quality of Life in Children with Cerebral Palsy after Selective Dorsal Rhizotomy

Wong, Matthew H.

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

Wortmann, Saskia B.

P 233. Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder

Wortmann-Hagemann, Saskia

P 605. Epileptic Encephalopathy Caused by Mitochondrial MPC-1 Deficiency Can Benefit from Ketogenic Diet—Significance of Early Genetic Testing for a Targeted Therapy

Wright, Stephen

IP 110. Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet’s Syndrome: Results of an Open-Label Extension Trial (GWPCARE5)

Wunderlich, Gilbert

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B

Youssef, Hudda

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

Zaqout, Sami

P 306. Role of Cdk5rap2 in Neocortical Development

P 1086. Role of PTRH2 in Cerebellar Development

Zech, Michael

FV 1031. Whole Exome Sequencing for Children with Dyskinetic Movement Disorder

Zieger, Barbara

FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire

Ziegler, Andreas

P 605. Epileptic Encephalopathy Caused by Mitochondrial MPC-1 Deficiency Can Benefit from Ketogenic Diet—Significance of Early Genetic Testing for a Targeted Therapy

P 705. Axenfeld-Rieger Anomaly and Neuropsychiatric Symptoms

P 520. Unclear Strokes in Pediatrics—Adenosine Deaminase 2 (ADA2) Deficiency as a Therapeutic Relevant Differential Diagnosis to Acquired Inflammatory CNS Diseases

P 780. Misdiagnosis of Child Abuse—Fibrodysplasia Ossificans Progressiva as a Therapy-Relevant Differential Diagnosis in Infancy

Zielen, Stefan

P 1092. The Challenging Nature of Cerebral TBC Manifestations in Children and Young Adults

P 1103. Fatal Outcome of Metapneumovirus Infection in Patient with 4H Syndrome

Zielonka, Matthias

P 781. A Cross-sectional Quantitative Analysis of the Natural History of Farber Disease: An Ultra-Orphan Condition with Rheumatologic and Neurological Cardinal Disease Features

Zweier, Christiane

P 1008. Neuronal Migration Disorders in Infants with 22q11.2 Deletion Syndrome—Two Case Reports

Żołnowska, Marta

IP 110. Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet’s Syndrome: Results of an Open-Label Extension Trial (GWPCARE5)